美國FDA點頭同意 康霈局部減脂新藥臨床試驗獲新進展
鏡傳媒· 3 日前康霈生技宣布旗下新藥CBL-514用於減少皮下脂肪(非手術局部減脂)之Phase 2b臨床試驗已獲美國食品藥物 ...
How To Leverage Experiential Intelligence For Greater Success And Impact
Forbes· 3 日前In coaching and training thousands of professionals over the past 17 years, and in my former ...
6 Ways Leaders Can Stay Ahead Of Disruption In 2023
Forbes· 22 小時前Along with streaming operations and cutting costs where it counts, they will be planning to stay a step ahead of the disruption ...